Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 111   

Articles published

SHP 4,193.00 +29.00 (0.70%)
price chart
Was AbbVie Inc. Wrong to Abandon Its Deal With Shire plc?
Tax inversions are dead. The Treasury Department made sure of that in September, when it released a shopping list of changes to rein in proposed transactions like the one previously planned between AbbVie (NYSE: ABBV ) and Shire plc (NASDAQ: SHPG ) ...
AbbVie's Threat on Shire Deal Is Latest Tax Rule Fallout
AbbVie Inc. (ABBV) may scrap its planned 32.4-billion-pound ($51.5 billion) deal for Dublin-based drugmaker Shire Plc (SHP), in what would be the biggest casualty of the U.S.
Why Shire plc (ADR) Is Today's Worst Biotech Stock  Motley Fool
Shire PLC's Shares Collapse As AbbVie Inc Reconsiders  The Motley Fool UK
Related articles »  
AbbVie says $55 billion acquisition of Shire officially dead
(Reuters) - U.S. drugmaker AbbVie Inc (ABBV.N) said on Monday it has reached agreement with Shire Plc (SHP.L) to officially call off its proposed $55 billion purchase of the Irish company, and will pay Shire a $1.64 billion breakup fee for walking away ...
Is Shire PLC A Buy After AbbVie Inc Withdraws Takeover Offer?  The Motley Fool UK
Turning Away From Shire May Cost AbbVie More Than Lost Tax Savings  Bidness ETC
Related articles »  
Shire PLC Takes a Dive as AbbVie Reconsiders Offer
Billionaire stock picks Paramount Gold and Silver Corp. (NYSEMKT:PZG), Nanosphere, Inc. (NASDAQ:NSPH) and Orexigen Therapeutics, Inc. (NASDAQ:OREX) have made noteworthy climbs on the market this Wednesday.
Shire PLC Upgraded to Buy by CRT Capital (SHPGY)  WKRB News
Shire PLC Upgraded to Buy by CRT Capital (SHPG)  Ticker Report
Related articles »  
If You Purchased Shire plc American Depository Receipts ("ADRs") During The ...
If you invested in Shire plc ADRs following announcement of combination discussions on June 20, 2014 until October 14, 2014 and would like to discuss your legal rights, call Mark Gardy or Kira German at 212-905-0509 or e-mail mgardy@gardylaw.
AbbVie Expected To Post Mixed Q3 Results  Bidness ETC
Related articles »  
Top Allergan holder Paulson urges deal with Shire: sources
(Reuters) - Allergan Inc (AGN.N) shareholder Paulson & Co is urging the Botox maker to merge with specialty pharmaceutical company Shire Plc (SHP.L) as an alternative to a deal with hostile bidder Valeant Pharmaceuticals International Inc (VRX.TO) ...
Allergan Might Approach Shire For Acquisition  Bidness ETC
Related articles »  
Investment Analysts' Recent Ratings Updates for Shire PLC (SHPG)
Shire PLC was upgraded by analysts at SunTrust from a �neutral� rating to a �buy� rating. They now have a $225.00 price target on the stock, down previously from $269.00.
Shire PLC Receives Consensus Rating of "Buy" from Analysts (NASDAQ ...  Intercooler
Related articles »  
Shire PLC Rating Reiterated by JPMorgan Chase & Co. (SHPGY)
Shire PLC (NASDAQ:SHPGY)'s stock had its �overweight� rating reaffirmed by investment analysts at JPMorgan Chase & Co.
Why GlaxoSmithKline plc And Shire PLC Could Be The Perfect Pharmaceutical ...
It's been a mixed year for investors in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and Shire (LSE: SHP) (NASDAQ: SHPG.US).
Why Shire PLC, Hikma Pharmaceuticals Plc And BTG plc Could Complement ...
However, it could be complemented in Foolish portfolios by sector peers such as Shire, BTG (LSE: BTG) and Hikma (LSE: HIK).
Related articles »